NDC 0032-0047 – Creon

Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase 12000 [USP'U]/1; Pancrelipase Protease 38000 [USP'U]/1 · Capsule, Delayed Release Pellets · Oral

Human Prescription Drug 2 recalls

Product NDC0032-0047

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release Pellets
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
October 12, 2023
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (2)

Package NDCDescriptionSince
0032-0047-30 sample100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-0047-30)Oct 12, 2023
0032-0047-70100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-0047-70)Oct 12, 2023

Recalls mentioning this NDC

Other Creon products